{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:11:06Z","timestamp":1789495866744,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40257-018-0409-y","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T01:49:48Z","timestamp":1546393788000},"page":"237-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Off-Label Use of Topical Minoxidil in Alopecia: A Review"],"prefix":"10.1007","volume":"20","author":[{"given":"Jenna R.","family":"Stoehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Colavincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8987-473X","authenticated-orcid":false,"given":"Stefan","family":"Vanderweil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"issue":"10","key":"409_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1056\/NEJM197003052821001","volume":"282","author":"E Gilmore","year":"1970","unstructured":"Gilmore E, Weil J, Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970;282(10):521\u20137.","journal-title":"N Engl J Med."},{"issue":"3","key":"409_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/01.CIR.45.3.571","volume":"45","author":"TB Gottlieb","year":"1972","unstructured":"Gottlieb TB, Katz FH, Chidsey CA 3rd. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation. 1972;45(3):571\u201382.","journal-title":"Circulation."},{"issue":"6088","key":"409_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/bmj.2.6088.667","volume":"2","author":"BL Devine","year":"1977","unstructured":"Devine BL, Fife R, Trust PM. Minoxidil for severe hypertension after failure of other hypotensive drugs. Br Med J. 1977;2(6088):667\u20139.","journal-title":"Br Med J."},{"issue":"1\u20132","key":"409_CR4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0954-6820.1978.tb14829.x","volume":"203","author":"M Oka","year":"1978","unstructured":"Oka M, Makela M. Minoxidil in severe hypertension. Acta Med Scand. 1978;203(1\u20132):43\u20137.","journal-title":"Acta Med Scand."},{"key":"409_CR5","unstructured":"Lester W. Hair-raising tale: no fame for men who discovered Rogaine. The Daily Gazette. 1996. p. 17."},{"key":"409_CR6","unstructured":"US FDA. Rogaine (for Men). Report No.: NDA: 019501. Silver Spring, MD: US FDA"},{"key":"409_CR7","unstructured":"Associated Press. Hair-Growth Drug to Be Sold Over the Counter. New York Times. February 13, 1996."},{"issue":"2","key":"409_CR8","first-page":"185","volume":"8","author":"C Goh","year":"2009","unstructured":"Goh C, Zippin JH. Androgenetic alopecia: diagnosis and treatment with a focus on recent genetic implications. J Drugs Dermatol. 2009;8(2):185\u201392.","journal-title":"J Drugs Dermatol."},{"issue":"11","key":"409_CR9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archderm.1987.01660350083018","volume":"123","author":"JA Koperski","year":"1987","unstructured":"Koperski JA, Orenberg EK, Wilkinson DI. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Arch Dermatol. 1987;123(11):1483\u20137.","journal-title":"Arch Dermatol."},{"issue":"3 Pt 2","key":"409_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0190-9622(87)70087-5","volume":"16","author":"RL Rietschel","year":"1987","unstructured":"Rietschel RL, Duncan SH. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia. J Am Acad Dermatol. 1987;16(3 Pt 2):677\u201385.","journal-title":"J Am Acad Dermatol."},{"issue":"5","key":"409_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/1523-1747.ep12261084","volume":"82","author":"RC Wester","year":"1984","unstructured":"Wester RC, Maibach HI, Guy RH, Novak E. Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol. 1984;82(5):515\u20137.","journal-title":"J Invest Dermatol."},{"issue":"2","key":"409_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","volume":"150","author":"AG Messenger","year":"2004","unstructured":"Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186\u201394.","journal-title":"Br J Dermatol."},{"issue":"3","key":"409_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","volume":"15","author":"S Varothai","year":"2014","unstructured":"Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):217\u201330.","journal-title":"Am J Clin Dermatol."},{"issue":"6","key":"409_CR14","first-page":"371","volume":"96","author":"TG Phillips","year":"2017","unstructured":"Phillips TG, Slomiany WP, Allison R. Hair loss: common causes and treatment. Am Fam Physician. 2017;96(6):371\u20138.","journal-title":"Am Fam Physician."},{"issue":"9","key":"409_CR15","first-page":"WE01","volume":"9","author":"S Malkud","year":"2015","unstructured":"Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01\u20133.","journal-title":"J Clin Diagn Res."},{"key":"409_CR16","volume-title":"Telogen effluvium","author":"EC Hughes","year":"2018","unstructured":"Hughes EC, Taneja A. Telogen effluvium. Treasure Island: StatPearls Publishing; 2018."},{"issue":"9","key":"409_CR17","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archderm.135.9.1123","volume":"135","author":"MJ Garcia-Hernandez","year":"1999","unstructured":"Garcia-Hernandez MJ, Camacho FM. Chronic telogen effluvium: incidence, clinical and biochemical features, and treatment. Arch Dermatol. 1999;135(9):1123\u20134.","journal-title":"Arch Dermatol."},{"issue":"5","key":"409_CR18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1034\/j.1600-0625.2003.00028.x","volume":"12","author":"PC Arck","year":"2003","unstructured":"Arck PC, Handjiski B, Peters EM, Hagen E, Klapp BF, Paus R. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol. 2003;12(5):580\u201390.","journal-title":"Exp Dermatol."},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.12688\/f1000research.11775.1","volume":"6","author":"E Perera","year":"2017","unstructured":"Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study. F1000Res. 2017;6:1650.","journal-title":"F1000Res."},{"issue":"1","key":"409_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2310\/7750.2014.13200","volume":"19","author":"AA Dmytriw","year":"2015","unstructured":"Dmytriw AA, Morzycki W, Green PJ. Prevention of alopecia in medical and interventional chemotherapy patients. J Cutan Med Surg. 2015;19(1):11\u20136.","journal-title":"J Cutan Med Surg."},{"issue":"3","key":"409_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40257-014-0086-4","volume":"15","author":"M Hordinsky","year":"2014","unstructured":"Hordinsky M, Donati A. Alopecia areata: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):231\u201346.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"409_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-4362.1985.tb05774.x","volume":"24","author":"GM Galbraith","year":"1985","unstructured":"Galbraith GM, Thiers BH. In vitro suppression of human lymphocyte activity by minoxidil. Int J Dermatol. 1985;24(4):249\u201351.","journal-title":"Int J Dermatol."},{"issue":"5","key":"409_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/archderm.1986.01660170030011","volume":"122","author":"YP Shi","year":"1986","unstructured":"Shi YP. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia. Arch Dermatol. 1986;122(5):506.","journal-title":"Arch Dermatol."},{"issue":"6398","key":"409_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/bmj.287.6398.1015","volume":"287","author":"DA Fenton","year":"1983","unstructured":"Fenton DA, Wilkinson JD. Topical minoxidil in the treatment of alopecia areata. Br Med J (Clin Res Ed). 1983;287(6398):1015\u20137.","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"11","key":"409_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","volume":"128","author":"EA Olsen","year":"1992","unstructured":"Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol. 1992;128(11):1467\u201373.","journal-title":"Arch Dermatol."},{"issue":"2 Suppl","key":"409_CR26","first-page":"S19","volume":"16","author":"MM Chowdhury","year":"2007","unstructured":"Chowdhury MM, Rahman MH, Wahab MA. Efficacy of combination therapy for the management regime of Alopecia areata. Mymensingh Med J. 2007;16(2 Suppl):S19\u201322.","journal-title":"Mymensingh Med J."},{"issue":"5","key":"409_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/archderm.1985.01660050039009","volume":"121","author":"SI White","year":"1985","unstructured":"White SI, Friedmann PS. Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol. 1985;121(5):591.","journal-title":"Arch Dermatol."},{"issue":"2","key":"409_CR28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2340\/0001555566179180","volume":"66","author":"JP Vestey","year":"1986","unstructured":"Vestey JP, Savin JA. A trial of 1% minoxidil used topically for severe alopecia areata. Acta Derm Venereol. 1986;66(2):179\u201380.","journal-title":"Acta Derm Venereol."},{"issue":"5 Pt 1","key":"409_CR29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0190-9622(93)70238-O","volume":"29","author":"J Shapiro","year":"1993","unstructured":"Shapiro J, Tan J, Ho V, Abbott F, Tron V. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. J Am Acad Dermatol. 1993;29(5 Pt 1):729\u201335.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"409_CR30","first-page":"431","volume":"41","author":"AF Fransway","year":"1988","unstructured":"Fransway AF, Muller SA. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. Cutis. 1988;41(6):431\u20135.","journal-title":"Cutis."},{"issue":"3 Pt 2","key":"409_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0190-9622(87)70096-6","volume":"16","author":"VH Price","year":"1987","unstructured":"Price VH. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy. J Am Acad Dermatol. 1987;16(3 Pt 2):737\u201344.","journal-title":"J Am Acad Dermatol."},{"issue":"9","key":"409_CR32","first-page":"1012","volume":"14","author":"ME Farhangian","year":"2015","unstructured":"Farhangian ME, McMichael AJ, Huang KE, Feldman SR. Treatment of alopecia areata in the united states: a retrospective cross-sectional study. J Drugs Dermatol. 2015;14(9):1012\u20134.","journal-title":"J Drugs Dermatol."},{"issue":"5","key":"409_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jaad.2017.06.035","volume":"77","author":"CC Caldwell","year":"2017","unstructured":"Caldwell CC, Saikaly SK, Dellavalle RP, Solomon JA. Prevalence of pediatric alopecia areata among 572,617 dermatology patients. J Am Acad Dermatol. 2017;77(5):980\u20131.","journal-title":"J Am Acad Dermatol."},{"key":"409_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fmed.2017.00112","volume":"4","author":"L Xu","year":"2017","unstructured":"Xu L, Liu KX, Senna MM. A practical approach to the diagnosis and management of hair loss in children and adolescents. Front Med (Lausanne). 2017;4:112.","journal-title":"Front Med (Lausanne)."},{"issue":"2 Suppl 1","key":"409_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jaad.2004.06.024","volume":"52","author":"P Lenane","year":"2005","unstructured":"Lenane P, Pope E, Krafchik B. Congenital alopecia areata. J Am Acad Dermatol. 2005;52(2 Suppl 1):8\u201311.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"409_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/2229-5178.202269","volume":"8","author":"AK Rai","year":"2017","unstructured":"Rai AK. Minoxidil-induced hypertrichosis in a child with alopecia areata. Indian Dermatol Online J. 2017;8(2):147\u20138.","journal-title":"Indian Dermatol Online J."},{"issue":"2","key":"409_CR37","first-page":"226","volume":"F1000Res","author":"I Herskovitz","year":"2013","unstructured":"Herskovitz I, Freedman J, Tosti A. Minoxidil induced hypertrichosis in a 2 year-old child. 2013;F1000Res(2):226.","journal-title":"Minoxidil induced hypertrichosis in a 2 year-old child."},{"key":"409_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.11604\/pamj.2014.18.8.3637","volume":"18","author":"N Guerouaz","year":"2014","unstructured":"Guerouaz N, Mohamed AO. Minoxidil induced hypertrichosis in children. Pan Afr Med J. 2014;18:8.","journal-title":"Pan Afr Med J."},{"issue":"1","key":"409_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/abd1806-4841.20164010","volume":"91","author":"G Rampon","year":"2016","unstructured":"Rampon G, Henkin C, de Souza PR, Almeida HL Jr. Infantile generalized hypertrichosis caused by topical minoxidil. An Bras Dermatol. 2016;91(1):87\u20138.","journal-title":"An Bras Dermatol."},{"issue":"1","key":"409_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000096924","volume":"214","author":"S Georgala","year":"2007","unstructured":"Georgala S, Befon A, Maniatopoulou E, Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology. 2007;214(1):101\u20132.","journal-title":"Dermatology."},{"issue":"4","key":"409_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1590\/abd1806-4841.20152845","volume":"90","author":"A Tanus","year":"2015","unstructured":"Tanus A, Oliveira CC, Villarreal DJ, Sanchez FA, Dias MF. Black women\u2019s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity. Bras Dermatol. 2015;90(4):450\u201365.","journal-title":"Bras Dermatol."},{"issue":"6","key":"409_CR42","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1001\/archderm.1994.01690060100013","volume":"130","author":"S Kossard","year":"1994","unstructured":"Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130(6):770\u20134.","journal-title":"Arch Dermatol."},{"issue":"4","key":"409_CR43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2013.12.003","volume":"70","author":"S Vano-Galvan","year":"2014","unstructured":"Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, Arias-Santiago S, Rodrigues-Barata AR, Garnacho-Saucedo G, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014;70(4):670\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"409_CR44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1468-3083.2005.01291.x","volume":"19","author":"D Moreno-Ramirez","year":"2005","unstructured":"Moreno-Ramirez D, Camacho Martinez F. Frontal fibrosing alopecia: a survey in 16 patients. J Eur Acad Dermatol Venereol. 2005;19(6):700\u20135.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"12","key":"409_CR45","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/jdv.12139","volume":"27","author":"E Racz","year":"2013","unstructured":"Racz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol. 2013;27(12):1461\u201370.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"409_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaad.2004.05.014","volume":"52","author":"A Tosti","year":"2005","unstructured":"Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol. 2005;52(1):55\u201360.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"409_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ad.2016.11.012","volume":"108","author":"L Esteban-Lucia","year":"2017","unstructured":"Esteban-Lucia L, Molina-Ruiz AM, Requena L. Update on frontal fibrosing alopecia. Actas Dermosifiliogr. 2017;108(4):293\u2013304.","journal-title":"Actas Dermosifiliogr."},{"issue":"6","key":"409_CR48","first-page":"37","volume":"5","author":"EC Davis","year":"2012","unstructured":"Davis EC, Reid SD, Callender VD, Sperling LC. Differentiating central centrifugal cicatricial alopecia and androgenetic alopecia in african american men: report of three cases. J Clin Aesthet Dermatol. 2012;5(6):37\u201340.","journal-title":"J Clin Aesthet Dermatol."},{"key":"409_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/CCID.S100816","volume":"9","author":"I Herskovitz","year":"2016","unstructured":"Herskovitz I, Miteva M. Central centrifugal cicatricial alopecia: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:175\u201381.","journal-title":"Clin Cosmet Investig Dermatol."},{"issue":"11","key":"409_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/DAD.0000000000000174","volume":"36","author":"M Miteva","year":"2014","unstructured":"Miteva M, Tosti A. Pathologic diagnosis of central centrifugal cicatricial alopecia on horizontal sections. Am J Dermatopathol. 2014;36(11):859\u201364 (quiz 65\u20137).","journal-title":"Am J Dermatopathol."},{"issue":"6 Suppl","key":"409_CR51","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1067\/mjd.2003.278","volume":"48","author":"AJ McMichael","year":"2003","unstructured":"McMichael AJ. Ethnic hair update: past and present. J Am Acad Dermatol. 2003;48(6 Suppl):S127\u201333.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"409_CR52","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jaad.2008.09.066","volume":"60","author":"RC Gathers","year":"2009","unstructured":"Gathers RC, Lim HW. Central centrifugal cicatricial alopecia: past, present, and future. J Am Acad Dermatol. 2009;60(4):660\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"409_CR53","first-page":"317","volume":"16","author":"A Eginli","year":"2017","unstructured":"Eginli A, Dothard E, Bagayoko CW, Huang K, Daniel A, McMichael AJ. A retrospective review of treatment results for patients with central centrifugal cicatrical alopecia. J Drugs Dermatol. 2017;16(4):317\u201320.","journal-title":"J Drugs Dermatol."},{"issue":"3","key":"409_CR54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaad.2016.02.1162","volume":"75","author":"A Haskin","year":"2016","unstructured":"Haskin A, Aguh C. All hairstyles are not created equal: what the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA). J Am Acad Dermatol. 2016;75(3):606\u201311.","journal-title":"J Am Acad Dermatol."},{"issue":"11","key":"409_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D325M840MZ","volume":"17","author":"A Samrao","year":"2011","unstructured":"Samrao A, Price VH, Zedek D, Mirmirani P. The, \u201cFringe Sign\u201d: a useful clinical finding in traction alopecia of the marginal hair line. Dermatol Online J. 2011;17(11):1.","journal-title":"Dermatol Online J."},{"issue":"2","key":"409_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijwd.2015.04.002","volume":"1","author":"CN Lawson","year":"2015","unstructured":"Lawson CN, Hollinger J, Sethi S, Rodney I, Sarkar R, Dlova N, et al. Updates in the understanding and treatments of skin & hair disorders in women of color. Int J Womens Dermatol. 2015;1(2):59\u201375.","journal-title":"Int J Womens Dermatol."},{"issue":"3","key":"409_CR57","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1468-3083.2006.01933.x","volume":"21","author":"NP Khumalo","year":"2007","unstructured":"Khumalo NP, Ngwanya RM. Traction alopecia: 2% topical minoxidil shows promise. Report of two cases. J Eur Acad Dermatol Venereol. 2007;21(3):433\u20134.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"409_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/13543784.2017.1303480","volume":"26","author":"YL Barron-Hernandez","year":"2017","unstructured":"Barron-Hernandez YL, Tosti A. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Expert Opin Investig Drugs. 2017;26(4):515\u201322.","journal-title":"Expert Opin Investig Drugs."},{"key":"409_CR59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D3206022868","volume":"20","author":"IJ Vergilis-Kalner","year":"2014","unstructured":"Vergilis-Kalner IJ. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases. Dermatol Online J. 2014;20:6.","journal-title":"Dermatol Online J."},{"issue":"10","key":"409_CR60","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1346-8138.2012.01579.x","volume":"39","author":"W Suwanchatchai","year":"2012","unstructured":"Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012;39(10):865\u20136.","journal-title":"J Dermatol."},{"issue":"9","key":"409_CR61","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1346-8138.2010.00872.x","volume":"37","author":"E Civas","year":"2010","unstructured":"Civas E, Aksoy B, Aksoy HM, Eski M, Yucel K. Hair transplantation for therapy-resistant alopecia areata of the eyebrows: is it the right choice? J Dermatol. 2010;37(9):823\u20136.","journal-title":"J Dermatol."},{"issue":"8","key":"409_CR62","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1524-4725.2011.02037.x","volume":"37","author":"M Toscani","year":"2011","unstructured":"Toscani M, Fioramonti P, Ciotti M, Scuderi N. Single follicular unit hair transplantation to restore eyebrows. Dermatol Surg. 2011;37(8):1153\u20138.","journal-title":"Dermatol Surg."},{"issue":"2","key":"409_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/1346-8138.12275","volume":"41","author":"S Lee","year":"2014","unstructured":"Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014;41(2):149\u201352.","journal-title":"J Dermatol."},{"issue":"3","key":"409_CR64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jdcr.2016.02.011","volume":"2","author":"R Sinclair","year":"2016","unstructured":"Sinclair R. Treatment of monilethrix with oral minoxidil. JAAD Case Rep. 2016;2(3):212\u20135.","journal-title":"JAAD Case Rep."},{"issue":"3","key":"409_CR65","first-page":"243","volume":"58","author":"AG Vikramkumar","year":"2013","unstructured":"Vikramkumar AG, Kuruvila S, Ganguly S. Monilethrix: a rare hereditary condition. Indian J Dermatol. 2013;58(3):243.","journal-title":"Indian J Dermatol."},{"issue":"1","key":"409_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/039463201102400129","volume":"24","author":"A Rossi","year":"2011","unstructured":"Rossi A, Iorio A, Scali E, Fortuna MC, Mari E, Palese E, et al. Monilethrix treated with minoxidil. Int J Immunopathol Pharmacol. 2011;24(1):239\u201342.","journal-title":"Int J Immunopathol Pharmacol."},{"issue":"1","key":"409_CR67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1590\/abd1806-4841.20153357","volume":"90","author":"EF Oliveira","year":"2015","unstructured":"Oliveira EF, Araripe AL. Monilethrix: a typical case report with microscopic and dermatoscopic findings. An Bras Dermatol. 2015;90(1):126\u20137.","journal-title":"An Bras Dermatol."},{"issue":"5","key":"409_CR68","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/pde.12894","volume":"33","author":"G Singh","year":"2016","unstructured":"Singh G, Miteva M. Prognosis and management of congenital hair shaft disorders with fragility-part I. Pediatr Dermatol. 2016;33(5):473\u201380.","journal-title":"Pediatr Dermatol."},{"issue":"3","key":"409_CR69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1517\/17460441.2015.1009892","volume":"10","author":"Z Santos","year":"2015","unstructured":"Santos Z, Avci P, Hamblin MR. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov. 2015;10(3):269\u201392.","journal-title":"Expert Opin Drug Discov."},{"issue":"4","key":"409_CR70","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1529-8019.2011.01430.x","volume":"24","author":"CE Yeager","year":"2011","unstructured":"Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther. 2011;24(4):432\u201342.","journal-title":"Dermatol Ther."},{"issue":"34","key":"409_CR71","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1200\/JCO.2007.15.9053","volume":"26","author":"K Lotfi-Jam","year":"2008","unstructured":"Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol. 2008;26(34):5618\u201329.","journal-title":"J Clin Oncol."},{"issue":"5","key":"409_CR72","doi-asserted-by":"publisher","first-page":"E442","DOI":"10.1002\/ijc.29115","volume":"136","author":"H Shin","year":"2015","unstructured":"Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015;136(5):E442\u201354.","journal-title":"Int J Cancer."},{"issue":"1","key":"409_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","volume":"35","author":"M Duvic","year":"1996","unstructured":"Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996;35(1):74\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"409_CR74","first-page":"129","volume":"12","author":"CO Granai","year":"1991","unstructured":"Granai CO, Frederickson H, Gajewski W, Goodman A, Goldstein A, Baden H. The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaecol Oncol. 1991;12(2):129\u201332.","journal-title":"Eur J Gynaecol Oncol."},{"issue":"8","key":"409_CR75","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/oxfordjournals.annonc.a058986","volume":"5","author":"R Rodriguez","year":"1994","unstructured":"Rodriguez R, Machiavelli M, Leone B, Romero A, Cuevas MA, Langhi M, et al. Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia. Ann Oncol. 1994;5(8):769\u201370.","journal-title":"Ann Oncol."},{"issue":"2","key":"409_CR76","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","volume":"63","author":"B Tallon","year":"2010","unstructured":"Tallon B, Blanchard E, Goldberg LJ. Permanent chemotherapy-induced alopecia: case report and review of the literature. J Am Acad Dermatol. 2010;63(2):333\u20136.","journal-title":"J Am Acad Dermatol."},{"issue":"11","key":"409_CR77","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/annonc\/mds095","volume":"23","author":"N Kluger","year":"2012","unstructured":"Kluger N, Jacot W, Frouin E, Rigau V, Poujol S, Dereure O, et al. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. Ann Oncol. 2012;23(11):2879\u201384.","journal-title":"Ann Oncol."},{"issue":"2","key":"409_CR78","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1440-0960.2000.00405.x","volume":"41","author":"D Tran","year":"2000","unstructured":"Tran D, Sinclair RD, Schwarer AP, Chow CW. Permanent alopecia following chemotherapy and bone marrow transplantation. Australas J Dermatol. 2000;41(2):106\u20138.","journal-title":"Australas J Dermatol."},{"issue":"4","key":"409_CR79","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2133.2009.09043.x","volume":"160","author":"C Prevezas","year":"2009","unstructured":"Prevezas C, Matard B, Pinquier L, Reygagne P. Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer. Br J Dermatol. 2009;160(4):883\u20135.","journal-title":"Br J Dermatol."},{"issue":"4","key":"409_CR80","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1111\/ajd.12350","volume":"57","author":"X Yang","year":"2016","unstructured":"Yang X, Thai KE. Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil. Australas J Dermatol. 2016;57(4):e130\u20132.","journal-title":"Australas J Dermatol."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0409-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-018-0409-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0409-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T12:26:32Z","timestamp":1694521592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-018-0409-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-0409-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"2 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jenna R. Stoehr, Jennifer N. Choi, Maria Colavincenzo, and Stefan Vanderweil have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No sources of funding were used for the preparation of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}